MAPT and Alzheimer disease: A recent study by Okamura et al. demonstrated that [18F]THK-5105 tracer successfully bound in sites subjected to tau deposition in the AD [176], while another study showed that [18F]THK-523 tracer failed to demonstrate such tau deposition in human brain [181].